Drug profile · INN
oxyphencyclimine hydrochloride
DARICON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
oxyphencyclimine hydrochloride (DARICON) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN oxyphencyclimine hydrochloride
Brand DARICON
Route ORAL
Formulation TABLET
Frequently asked questions
What is oxyphencyclimine hydrochloride?
oxyphencyclimine hydrochloride (DARICON) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oxyphencyclimine hydrochloride?
DARICON is a marketed brand name for oxyphencyclimine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxyphencyclimine hydrochloride?
oxyphencyclimine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.